BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3500228)

  • 1. Enhancement of in vivo immune response by tumor necrosis factor.
    Ghiara P; Boraschi D; Nencioni L; Ghezzi P; Tagliabue A
    J Immunol; 1987 Dec; 139(11):3676-9. PubMed ID: 3500228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.
    Nencioni L; Villa L; Tagliabue A; Antoni G; Presentini R; Perin F; Silvestri S; Boraschi D
    J Immunol; 1987 Aug; 139(3):800-4. PubMed ID: 2955051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.
    Mortensen RF; Shapiro J; Lin BF; Douches S; Neta R
    J Immunol; 1988 Apr; 140(7):2260-6. PubMed ID: 2450915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo.
    Boraschi D; Villa L; Volpini G; Bossù P; Censini S; Ghiara P; Scapigliat G; Nencioni L; Bartalini M; Matteucci G
    Eur J Immunol; 1990 Feb; 20(2):317-21. PubMed ID: 2311646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
    Hernández-Caselles T; Stutman O
    J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endogenous nitric oxide on tumour necrosis factor-alpha-induced leukosequestration and IL-8 release in guinea-pigs airways in vivo.
    Kuo HP; Hwang KH; Lin HC; Wang CH; Lu LC
    Br J Pharmacol; 1997 Sep; 122(1):103-11. PubMed ID: 9298535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice.
    Ryffel B; Di Padova F; Schreier MH; Le Hir M; Eugster HP; Quesniaux VF
    J Immunol; 1997 Mar; 158(5):2126-33. PubMed ID: 9036957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6.
    Mckenzie RC; Park ES; Brown WR; Shivji GS; Sauder DN
    Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):74-9. PubMed ID: 8043388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells.
    Barnum SR; Jones JL; Benveniste EN
    Glia; 1993 Mar; 7(3):225-36. PubMed ID: 8454308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A requirement for nonspecific T cell factors in antibody responses to "T cell independent" antigens.
    Endres RO; Kushnir E; Kappler JW; Marrack P; Kinsky SC
    J Immunol; 1983 Feb; 130(2):781-4. PubMed ID: 6336770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA; Kipps TJ
    Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1.
    Muchmore A; Decker J; Shaw A; Wingfield P
    Cancer Res; 1990 Oct; 50(19):6285-90. PubMed ID: 2400992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression.
    Pantschenko AG; Pushkar I; Miller LJ; Wang YP; Anderson K; Peled Z; Kurtzman SH; Kreutzer DL
    Oncol Rep; 2003; 10(4):1011-7. PubMed ID: 12792762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
    Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
    Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
    J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunoregulatory properties of recombinant human tumor necrosis factor-beta in mice opposite-reacting to antigen].
    Masycheva VI; Fadina VA; Danilenko ED; Sysoeva GM; Ratner GM; Stakheeva MN; Stepovaia EA; Khlusova MIu; Sherstoboev EIu; Pustoshilova NM
    Eksp Klin Farmakol; 1999; 62(4):44-7. PubMed ID: 10513336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.